Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2019

May 8, 2019

284_dirs_2019-05-07_cf02b56a-9b46-4bd8-a32b-10d8630bb28c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2019-05-03

Reporting Person: Davis Robert M (Evp, Global Svcs & CFO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-05-03 Stock Option (right to buy) $80.0000 A 112907.0000 Acquired 2029-05-02 Common Stock (112907.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 137659.7570 Direct

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.